Multicancer Detection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510243154

Publication Date:

October 17, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

Multicancer Detection refers to the ability to detect various types of cancer within the human body. It typically involves diagnostic methods or technologies that can identify cancerous cells or biomarkers associated with different cancer types simultaneously or in a single test.
The global market for Multicancer Detection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The development of liquid biopsy tests for multicancer detection is gaining momentum, allowing for early cancer detection through blood tests. Advancements in liquid biopsy technologies and the integration of AI for data analysis are notable trends.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Multicancer Detection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Multicancer Detection by region & country, by Type, and by Application.
The Multicancer Detection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multicancer Detection.
Market Segmentation
By Company
Agilent Technologies, Inc.
Atara Biotherapeutics, Inc.
Burning Rock DX
Danaher Corporation
Exact Sciences Corporation
Hoffmann-La Roche Ltd
Fulgent Genetics.
Genecast Biotechnology Co., Ltd
Guardant Health, Inc.
Illumina, Inc.
Konica Minolta, Inc.
Laboratory Corporation of America Holdings.
Myriad Genetics, Inc.
Tempus
Thermo Fisher Scientific Inc.
Segment by Type:
Laboratory Developed Tests (LDTs)
In-Vitro Diagnostics (IVDs)
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Multicancer Detection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Multicancer Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Multicancer Detection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Multicancer Detection Product Introduction
1.2 Global Multicancer Detection Market Size Forecast
1.3 Multicancer Detection Market Trends & Drivers
1.3.1 Multicancer Detection Industry Trends
1.3.2 Multicancer Detection Market Drivers & Opportunity
1.3.3 Multicancer Detection Market Challenges
1.3.4 Multicancer Detection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Multicancer Detection Players Revenue Ranking (2023)
2.2 Global Multicancer Detection Revenue by Company (2019-2024)
2.3 Key Companies Multicancer Detection Manufacturing Base Distribution and Headquarters
2.4 Key Companies Multicancer Detection Product Offered
2.5 Key Companies Time to Begin Mass Production of Multicancer Detection
2.6 Multicancer Detection Market Competitive Analysis
2.6.1 Multicancer Detection Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Multicancer Detection Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multicancer Detection as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Laboratory Developed Tests (LDTs)
3.1.2 In-Vitro Diagnostics (IVDs)
3.2 Global Multicancer Detection Sales Value by Type
3.2.1 Global Multicancer Detection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Multicancer Detection Sales Value, by Type (2019-2030)
3.2.3 Global Multicancer Detection Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Multicancer Detection Sales Value by Application
4.2.1 Global Multicancer Detection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Multicancer Detection Sales Value, by Application (2019-2030)
4.2.3 Global Multicancer Detection Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Multicancer Detection Sales Value by Region
5.1.1 Global Multicancer Detection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Multicancer Detection Sales Value by Region (2019-2024)
5.1.3 Global Multicancer Detection Sales Value by Region (2025-2030)
5.1.4 Global Multicancer Detection Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Multicancer Detection Sales Value, 2019-2030
5.2.2 North America Multicancer Detection Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Multicancer Detection Sales Value, 2019-2030
5.3.2 Europe Multicancer Detection Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Multicancer Detection Sales Value, 2019-2030
5.4.2 Asia Pacific Multicancer Detection Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Multicancer Detection Sales Value, 2019-2030
5.5.2 South America Multicancer Detection Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Multicancer Detection Sales Value, 2019-2030
5.6.2 Middle East & Africa Multicancer Detection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Multicancer Detection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Multicancer Detection Sales Value
6.3 United States
6.3.1 United States Multicancer Detection Sales Value, 2019-2030
6.3.2 United States Multicancer Detection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Multicancer Detection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Multicancer Detection Sales Value, 2019-2030
6.4.2 Europe Multicancer Detection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Multicancer Detection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Multicancer Detection Sales Value, 2019-2030
6.5.2 China Multicancer Detection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Multicancer Detection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Multicancer Detection Sales Value, 2019-2030
6.6.2 Japan Multicancer Detection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Multicancer Detection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Multicancer Detection Sales Value, 2019-2030
6.7.2 South Korea Multicancer Detection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Multicancer Detection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Multicancer Detection Sales Value, 2019-2030
6.8.2 Southeast Asia Multicancer Detection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Multicancer Detection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Multicancer Detection Sales Value, 2019-2030
6.9.2 India Multicancer Detection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Multicancer Detection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Profile
7.1.2 Agilent Technologies, Inc. Main Business
7.1.3 Agilent Technologies, Inc. Multicancer Detection Products, Services and Solutions
7.1.4 Agilent Technologies, Inc. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.1.5 Agilent Technologies, Inc. Recent Developments
7.2 Atara Biotherapeutics, Inc.
7.2.1 Atara Biotherapeutics, Inc. Profile
7.2.2 Atara Biotherapeutics, Inc. Main Business
7.2.3 Atara Biotherapeutics, Inc. Multicancer Detection Products, Services and Solutions
7.2.4 Atara Biotherapeutics, Inc. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.2.5 Atara Biotherapeutics, Inc. Recent Developments
7.3 Burning Rock DX
7.3.1 Burning Rock DX Profile
7.3.2 Burning Rock DX Main Business
7.3.3 Burning Rock DX Multicancer Detection Products, Services and Solutions
7.3.4 Burning Rock DX Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.3.5 Danaher Corporation Recent Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Profile
7.4.2 Danaher Corporation Main Business
7.4.3 Danaher Corporation Multicancer Detection Products, Services and Solutions
7.4.4 Danaher Corporation Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.4.5 Danaher Corporation Recent Developments
7.5 Exact Sciences Corporation
7.5.1 Exact Sciences Corporation Profile
7.5.2 Exact Sciences Corporation Main Business
7.5.3 Exact Sciences Corporation Multicancer Detection Products, Services and Solutions
7.5.4 Exact Sciences Corporation Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.5.5 Exact Sciences Corporation Recent Developments
7.6 Hoffmann-La Roche Ltd
7.6.1 Hoffmann-La Roche Ltd Profile
7.6.2 Hoffmann-La Roche Ltd Main Business
7.6.3 Hoffmann-La Roche Ltd Multicancer Detection Products, Services and Solutions
7.6.4 Hoffmann-La Roche Ltd Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.6.5 Hoffmann-La Roche Ltd Recent Developments
7.7 Fulgent Genetics.
7.7.1 Fulgent Genetics. Profile
7.7.2 Fulgent Genetics. Main Business
7.7.3 Fulgent Genetics. Multicancer Detection Products, Services and Solutions
7.7.4 Fulgent Genetics. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.7.5 Fulgent Genetics. Recent Developments
7.8 Genecast Biotechnology Co., Ltd
7.8.1 Genecast Biotechnology Co., Ltd Profile
7.8.2 Genecast Biotechnology Co., Ltd Main Business
7.8.3 Genecast Biotechnology Co., Ltd Multicancer Detection Products, Services and Solutions
7.8.4 Genecast Biotechnology Co., Ltd Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.8.5 Genecast Biotechnology Co., Ltd Recent Developments
7.9 Guardant Health, Inc.
7.9.1 Guardant Health, Inc. Profile
7.9.2 Guardant Health, Inc. Main Business
7.9.3 Guardant Health, Inc. Multicancer Detection Products, Services and Solutions
7.9.4 Guardant Health, Inc. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.9.5 Guardant Health, Inc. Recent Developments
7.10 Illumina, Inc.
7.10.1 Illumina, Inc. Profile
7.10.2 Illumina, Inc. Main Business
7.10.3 Illumina, Inc. Multicancer Detection Products, Services and Solutions
7.10.4 Illumina, Inc. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.10.5 Illumina, Inc. Recent Developments
7.11 Konica Minolta, Inc.
7.11.1 Konica Minolta, Inc. Profile
7.11.2 Konica Minolta, Inc. Main Business
7.11.3 Konica Minolta, Inc. Multicancer Detection Products, Services and Solutions
7.11.4 Konica Minolta, Inc. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.11.5 Konica Minolta, Inc. Recent Developments
7.12 Laboratory Corporation of America Holdings.
7.12.1 Laboratory Corporation of America Holdings. Profile
7.12.2 Laboratory Corporation of America Holdings. Main Business
7.12.3 Laboratory Corporation of America Holdings. Multicancer Detection Products, Services and Solutions
7.12.4 Laboratory Corporation of America Holdings. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.12.5 Laboratory Corporation of America Holdings. Recent Developments
7.13 Myriad Genetics, Inc.
7.13.1 Myriad Genetics, Inc. Profile
7.13.2 Myriad Genetics, Inc. Main Business
7.13.3 Myriad Genetics, Inc. Multicancer Detection Products, Services and Solutions
7.13.4 Myriad Genetics, Inc. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.13.5 Myriad Genetics, Inc. Recent Developments
7.14 Tempus
7.14.1 Tempus Profile
7.14.2 Tempus Main Business
7.14.3 Tempus Multicancer Detection Products, Services and Solutions
7.14.4 Tempus Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.14.5 Tempus Recent Developments
7.15 Thermo Fisher Scientific Inc.
7.15.1 Thermo Fisher Scientific Inc. Profile
7.15.2 Thermo Fisher Scientific Inc. Main Business
7.15.3 Thermo Fisher Scientific Inc. Multicancer Detection Products, Services and Solutions
7.15.4 Thermo Fisher Scientific Inc. Multicancer Detection Revenue (US$ Million) & (2019-2024)
7.15.5 Thermo Fisher Scientific Inc. Recent Developments
8 Industry Chain Analysis
8.1 Multicancer Detection Industrial Chain
8.2 Multicancer Detection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Multicancer Detection Sales Model
8.5.2 Sales Channel
8.5.3 Multicancer Detection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Agilent Technologies, Inc.
Atara Biotherapeutics, Inc.
Burning Rock DX
Danaher Corporation
Exact Sciences Corporation
Hoffmann-La Roche Ltd
Fulgent Genetics.
Genecast Biotechnology Co., Ltd
Guardant Health, Inc.
Illumina, Inc.
Konica Minolta, Inc.
Laboratory Corporation of America Holdings.
Myriad Genetics, Inc.
Tempus
Thermo Fisher Scientific Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂